← SynDRA
PHA-647A
SynDRA canonical compound SYN1963053 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | MMP1 | MMP13 | MMP14 | MMP2 | MMP3 | MMP8 | MMP9 |
|---|
| Mechanism of action | matrix metalloprotease inhibitor |
|---|
All known targets
- MMP1
- MMP13
- MMP14
- MMP2
- MMP3
- MMP8
- MMP9
Mechanisms of action (all sources)
- matrix metalloprotease inhibitor
Cross-references
Synonyms
- MMP inhibitors (anticancer)
- PNU-142485
- PNU-142769
- PNU-145254
- PNU-170830
- PNU-172769
- SC-276
- SC-277
- SC-511
- SC-581
- SC-595
- SC-774
- SC-77774
- SC-77964
- SC-78080
- SC-964
- SD-2590
- MMP inhibitors (anticancer), Pfizer
- MMP inhibitors (anticancer), Pharmacia
Look up PHA-647A in the interactive SynDRA portal →